Information about Orionis Biosciences
My details
*
*
*
No warnings for this company
{{translate('company_activity_bron_' + bron)}}
NACE Description
{{activiteit.code}} {{activiteit.description}}

Orionis Biosciences (SRL)

Company information
Status
Active
Enterprise number
BE0635.962.088
VAT liability
Yes
Established
02-09-2015
Last balance sheet year
2023
Company size
Medium-sized 34,2 FTE
Principal activity
Research and experimental development on biotechnology
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Orionis Biosciences

{{translate("download")}}

Publications in the Belgian Official Journal from Orionis Biosciences

Date Publication
08-10-2024 Resignations - Appointments (NL)
23-03-2023 Resignations - Appointments (NL)
11-08-2022 Resignations - Appointments (NL)
27-08-2021 Articles of Association (Translation, Coordination, Other Modifications, …) - General meeting (NL)
28-12-2020 Resignations - Appointments (NL)

Frequently asked questions

What is the VAT number of Orionis Biosciences?
The VAT number of Orionis Biosciences is BE0635962088.
When was Orionis Biosciences founded?
Orionis Biosciences was founded on 02-09-2015.
What is the address of Orionis Biosciences?
The current registered office of Orionis Biosciences is located at Technologiepark-Zwijnaarde 94, 9052 Gent.
When was the last time Orionis Biosciences filed their annual financial statements?
The most recent financial statements of Orionis Biosciences were filed on 13-07-2024. You can view them here.
How many employees does Orionis Biosciences have?
There are 34,2 FTEs working at Orionis Biosciences according to the staff figures in the most recent financial statements.
What is the annual turnover of Orionis Biosciences?
At the time of its most recent financial statements, Orionis Biosciences did not publish any turnover figures. Orionis Biosciences reported a gross margin of €4,650,437.00.